Τίτλος:
Elotuzumab, Pomalidomide, and Dexamethasone for Relapsed/Refractory
Multiple Myeloma: Efficacy After Additional Follow-Up of the ELOQUENT-3
Study
Συγγραφείς:
Dimopoulos, Meletios A.
Dytfeld, Dominik
Grosicki, Sebastian and
Moreau, Philippe
Takezako, Naoki
Hori, Mitsuo
Leleu, Xavier
and LeBlanc, Richard
Suzuki, Kenshi
Raab, Marc S. and
Richardson, Paul G.
McKiver, Mihaela Popa
Jou, Ying-Ming and
Shelat, Suresh G.
Robbins, Michael
Rafferty, Brian and
San-Miguel, Jesus